Cited by 483PI3K/AKT/mTOR signaling in cancerTuberous Sclerosis Complex ResearchProtein Kinase Regulation and GTPase Signaling

Rheb fills a GAP between TSC and TOR

Manning, B·2003·Trends in Biochemical Sciences

Abstract

There has been much interest in determining the molecular and cellular functions of hamartin and tuberin, which are encoded by the genes TSC1 and TSC2 that are mutated in the tuberous sclerosis complex disease. Recently, several laboratories have independently reported a major breakthrough in this field. Together, these genetic, biochemical and cell-biological studies have demonstrated that the tuberin-hamartin complex inhibits target of rapamycin (TOR) signaling by acting as a GTPase-activating protein for the Ras-related small G protein Rheb.

Integrity signals

Registry

Crossref · 10.1016/j.tibs.2003.09.003

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TSC1 and TSC2 are negative regulators of mTOR phosphorylation by blocking the small GTPase Rheb activity.

    “Recently, it has been demonstrated that two tumour suppressor genes, the tuberous sclerosis complex (TSC) gene TSC1 (or Hamartin) and TSC2 (or Tuberin) were negative regulators of mTOR phosphorylation [78] by blocking the small GTPase Rheb activity, which is a positive regulator of mTOR [79, 80].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Manning, B.
Affiliations
Beth Israel Deaconess Medical Center (US)
Corresponding author
Manning, B
Venue
Trends in Biochemical Sciences
Publisher
Elsevier BV
Published
2003-11
Volume
28
Issue
11
Pages
573-576
ISSN
0968-0004 (ISSN-L)
OpenAlex
W2036254130
Cited by
483
References
3
Citations by year
2026: 6 · 2025: 4 · 2024: 7 · 2023: 12 · 2022: 10 · 2021: 27 · 2020: 13 · 2019: 7 · 2018: 10 · 2017: 19 · 2016: 15 · 2015: 22 · 2014: 23 · 2013: 33 · 2012: 26
FWCI
13.45
Type
journal article
Language
en
Open access
closed
Locations
  • Trends in Biochemical Sciences (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Cancer Society
  • Tuberous Sclerosis Alliance
  • National Institute of General Medical Sciences (R01GM056203)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Health Sciences › Medicine › Physiology › Tuberous Sclerosis Complex Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords
Rheb, tuberin, hamartin, TSC1, TSC2, tuberous sclerosis complex, TOR signaling, GTPase-activating protein
MeSH terms
Ras Homolog Enriched in Brain Protein, Tuberous Sclerosis Complex 1 Protein, Tuberous Sclerosis Complex 2 Protein, Humans, Neuropeptides, Protein Kinases, Proteins, Repressor Proteins, Tuberous Sclerosis, Signal Transduction, Genes, Tumor Suppressor, Monomeric GTP-Binding Proteins, GTPase-Activating Proteins, Tumor Suppressor Proteins, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review